These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 32791278)

  • 1. Antithrombin III-mediated blood coagulation inhibitory activity of chitosan sulfate derivatized with different functional groups.
    Chandika P; Heo SY; Oh GW; Choi IW; Park WS; Jung WK
    Int J Biol Macromol; 2020 Oct; 161():1552-1558. PubMed ID: 32791278
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preparation and anticoagulation activity of sodium cellulose sulfate.
    Wang ZM; Li L; Zheng BS; Normakhamatov N; Guo SY
    Int J Biol Macromol; 2007 Oct; 41(4):376-82. PubMed ID: 17602735
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of functional groups on the in vitro anticoagulant activity of chitosan sulfate.
    Huang R; Du Y; Yang J; Fan L
    Carbohydr Res; 2003 Mar; 338(6):483-9. PubMed ID: 12668103
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification and function probing of an antithrombin IIIβ conformation-specific antibody.
    Jin Y; Yegneswaran S; Gu JM; Gritzan U; Schönfeld DL; Paz P; Patel C; Dittmer F; Strerath M; Bringmann P; Kauser K; Myles T; Murphy JE; Hermiston TW
    J Thromb Haemost; 2016 Feb; 14(2):356-65. PubMed ID: 26581031
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anticoagulant and antiprotease activities of a heparinoid sulfated glucoside-bearing polymer.
    Onishi M; Miyashita Y; Motomura T; Yamashita S; Sakamoto N; Akashi M
    J Biomater Sci Polym Ed; 1998; 9(9):973-84. PubMed ID: 9747989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design, synthesis, and biological activity of novel factor Xa inhibitors: improving metabolic stability by S1 and S4 ligand modification.
    Komoriya S; Kobayashi S; Osanai K; Yoshino T; Nagata T; Haginoya N; Nakamoto Y; Mochizuki A; Nagahara T; Suzuki M; Shimada T; Watanabe K; Isobe Y; Furugoori T
    Bioorg Med Chem; 2006 Mar; 14(5):1309-30. PubMed ID: 16263291
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DX-9065a inhibition of factor Xa and the prothrombinase complex: mechanism of inhibition and comparison with therapeutic heparins.
    Rezaie AR
    Thromb Haemost; 2003 Jan; 89(1):112-21. PubMed ID: 12540961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective carboxypropionylation of chitosan: synthesis, characterization, blood compatibility, and degradation.
    Xiong WY; Yi Y; Liu HZ; Wang H; Liu JH; Ying GQ
    Carbohydr Res; 2011 Jul; 346(10):1217-23. PubMed ID: 21549358
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of Sulfation and Molecular Weight on Anticoagulant Activity of Dextran.
    Drozd NN; Logvinova YS; Torlopov MA; Udoratina EV
    Bull Exp Biol Med; 2017 Feb; 162(4):462-465. PubMed ID: 28243911
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Orally active factor Xa inhibitor: synthesis and biological activity of masked amidines as prodrugs of novel 1,4-diazepane derivatives.
    Koshio H; Hirayama F; Ishihara T; Kaizawa H; Shigenaga T; Taniuchi Y; Sato K; Moritani Y; Iwatsuki Y; Uemura T; Kaku S; Kawasaki T; Matsumoto Y; Sakamoto S; Tsukamoto S
    Bioorg Med Chem; 2004 Oct; 12(20):5415-26. PubMed ID: 15388168
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sulfonation of papain-treated chitosan and its mechanism for anticoagulant activity.
    Suwan J; Zhang Z; Li B; Vongchan P; Meepowpan P; Zhang F; Mousa SA; Mousa S; Premanode B; Kongtawelert P; Linhardt RJ
    Carbohydr Res; 2009 Jul; 344(10):1190-6. PubMed ID: 19476923
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective disruption of heparin and antithrombin-mediated regulation of human factor IX.
    Westmark PR; Tanratana P; Sheehan JP
    J Thromb Haemost; 2015 Jun; 13(6):1053-63. PubMed ID: 25851619
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure- and property-based design of factor Xa inhibitors: pyrrolidin-2-ones with acyclic alanyl amides as P4 motifs.
    Young RJ; Campbell M; Borthwick AD; Brown D; Burns-Kurtis CL; Chan C; Convery MA; Crowe MC; Dayal S; Diallo H; Kelly HA; King NP; Kleanthous S; Mason AM; Mordaunt JE; Patel C; Pateman AJ; Senger S; Shah GP; Smith PW; Watson NS; Weston HE; Zhou P
    Bioorg Med Chem Lett; 2006 Dec; 16(23):5953-7. PubMed ID: 16982190
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anticoagulant property of a semi-synthesized sodium beta-1,4-glucan sulfate.
    Wang ZM; Li L; Li B; Guo SY
    Yao Xue Xue Bao; 2006 Apr; 41(4):323-7. PubMed ID: 16856476
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anticoagulant activity of a sulfated chitosan.
    Vongchan P; Sajomsang W; Subyen D; Kongtawelert P
    Carbohydr Res; 2002 Jul; 337(13):1239-42. PubMed ID: 12110200
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel anticoagulant protein with high affinity to blood coagulation factor Va from Tegillarca granosa.
    Jung WK; Jo HY; Qian ZJ; Jeong YJ; Park SG; Choi IW; Kim SK
    J Biochem Mol Biol; 2007 Sep; 40(5):832-8. PubMed ID: 17927919
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigation of the terminal P4 domain in a series of D-phenylglycinamide-based factor Xa inhibitors.
    Franciskovich JB; Masters JJ; Weber WW; Klimkowski VJ; Chouinard M; Sipes PR; Johnson LM; Snyder DW; Chastain MK; Craft TJ; Towner RD; Gifford-Moore DS; Froelich LL; Smallwood JK; Foster RS; Smith GF; Liebeschuetz JW; Murray CW; Young SC
    Bioorg Med Chem Lett; 2007 Dec; 17(24):6910-3. PubMed ID: 17976987
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and biological evaluation of direct thrombin inhibitors bearing 4-(piperidin-1-yl)pyridine at the P1 position with potent anticoagulant activity.
    de Candia M; Fiorella F; Lopopolo G; Carotti A; Romano MR; Lograno MD; Martel S; Carrupt PA; Belviso BD; Caliandro R; Altomare C
    J Med Chem; 2013 Nov; 56(21):8696-711. PubMed ID: 24102612
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterisation of the anticoagulant properties of a range of structurally diverse sulfated oligosaccharides.
    Wall D; Douglas S; Ferro V; Cowden W; Parish C
    Thromb Res; 2001 Aug; 103(4):325-35. PubMed ID: 11562342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel approach for preparation of heparins specific to factor Xa using affinity chromatography coupled with synthetic antithrombin III-related peptides.
    Onoue S; Harada S; Nemoto Y; Yajima T; Kashimoto K
    Peptides; 2003 Jun; 24(6):821-6. PubMed ID: 12948833
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.